Alnylam Pharmaceuticals | ALNY - 대출 자본

주가
311.10
매일 변경
-3.70 -1.18%
매월
-7.46%
매년
22.70%
Q1 예상
303.95




대출 자본 변화 날짜
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Incyte USD 30.2M 5.17M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Moderna USD 610M 584M 2025-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 150.06M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Takeda JPY 4.27T 81.29B 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Xencor USD 76.48M 11.29M 2025-12